Lawrence Nichols
Family Medicine · Hannibal, MONPI 1902885460
Payments from drug & device makers
Across 194 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$669
- AbbVie$602
- Novo Nordisk$521
- GSK$209
- Lilly USA, LLC$168
- Boehringer Ingelheim$160
- plus $883 from 21 others
What the payments were for
- Food & beverage$3,210100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 29 | $669 |
| AbbVie | 51 | $602 |
| Novo Nordisk | 27 | $521 |
| GSK | 13 | $209 |
| Lilly USA, LLC | 10 | $168 |
| Boehringer Ingelheim | 10 | $160 |
| Pfizer | 10 | $148 |
| Novartis | 7 | $108 |
| Lundbeck LLC | 5 | $85 |
| Bayer | 5 | $71 |
| Astellas Pharma US Inc | 2 | $50 |
| Johnson & Johnson | 3 | $47 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| Mylan Specialty L.p. | 2 | $38 |
| Teva Pharmaceuticals USA, Inc. | 2 | $32 |
| Exact Sciences | 2 | $31 |
| AstraZeneca | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $30 |
| Boston Scientific | 1 | $26 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Vertex | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
| Exeltis, USA Inc. | 1 | $15 |
| Sumitomo Pharma America, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,210 in reported general payments places this provider in the 80th percentile of 2,203 family medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 34 | $44,445 |
| EliquisApixaban | 45 | $33,426 |
| TrulicityDulaglutide | 29 | $28,810 |
| LinzessLinaclotide | 48 | $27,716 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 44 | $21,607 |
| MyrbetriqMirabegron | 23 | $14,929 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 452 | $14,445 |
| Spiriva HandihalerTiotropium Bromide | 17 | $12,825 |
| JardianceEmpagliflozin | 19 | $11,283 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,493 |
| Emgality PenGalcanezumab-Gnlm | 13 | $9,238 |
| Semglee (Yfgn) PenInsulin Glargine-Yfgn | 12 | $8,739 |
| SymbicortBudesonide/Formoterol Fumarate | 27 | $6,361 |
| Spiriva RespimatTiotropium Bromide | 12 | $6,352 |
| Omeprazole | 498 | $5,720 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimCombivent Respimat, Jardiance, Spiriva Respimat, Stiolto Respimat | $160 | $44,47586 claims |
| Novo NordiskOzempic | $521 | $44,44534 claims |
| PfizerEliquis | $148 | $33,42645 claims |
| Lilly USA, LLCTrulicity | $168 | $28,81029 claims |
| AbbVieLinzess | $602 | $27,71648 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $209 | $15,14026 claims |
| Astellas Pharma US IncMyrbetriq | $50 | $14,92923 claims |
| AstraZenecaSymbicort | $30 | $6,36127 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Hannibal
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
- George CarrJefferson City$2.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.